Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection

NCT03859128 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

402

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL: TORIPALIMAB INJECTION(JS001 )

Sponsor

Shanghai Junshi Bioscience Co., Ltd.